📑Fourniture de medicaments derives du sang pour le groupement de commande du Finistere
Procurement process summary
This process is to purchase Fourniture de medicaments derives du sang pour le groupement de commande du Finistere.
This contract was awarded by 🇫🇷 Chic Quimper/Concarneau for an amount of EUR 432,842 to 1 supplier. It was published on 2018-12-08 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇫🇷 Chic Quimper/Concarneau Buying unitnot reported Publication date2018-12-08 Contest statusnot reported DescriptionFourniture de medicaments derives du sang pour le groupement de commande du Finistere.Awards
This award was granted to Octapharma by Chic Quimper/Concarneau for an amount of EUR 432,842. The procurement process was conducted through open for the category of goods. The award was granted on 2019-02-01. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇫🇷 Octapharma | EUR 432,842 | 2019-02-01 | 1 |
Market context and opportunities
The execution of this contract allows the entity Chic Quimper/Concarneau to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberFR_ocds-70d2nz-7a749d5e-c7d2-4e78-b1f7-1264de3f3c26-award-1Publication date2018-12-08Contract datenot reportedAward date2019-02-01CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
